Nathalie Adda

Statistics

Publications

Citations

5.3K

H-Index

Active since

1999

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Goethe University Frankfurt

Cornell University

Duke Medical Center

The Royal Free Hospital

Nathalie Adda is an author at Vertex Pharmaceuticals (United States) specializing in pharmacotherapy, antiviral therapy, and antiviral pharmacotherapy.

Publications per year

1999–2022

Publications

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Ira M. Jacobson, John G. McHutchison, Geoffrey Dusheiko et al. · New England Journal of Medicine · 2011 · 2.4K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection

Kenneth E. Sherman, Steven L. Flamm, Nezam H. Afdhal et al. · New England Journal of Medicine · 2011 · 745 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Telaprevir for Previously Treated Chronic HCV Infection

John G. McHutchison, Michael P. Manns, Andrew J. Muir et al. · New England Journal of Medicine · 2010 · 719 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV

Mark Sulkowski, Kenneth E. Sherman, Douglas T. Dieterich et al. · Annals of Internal Medicine · 2013 · 200 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacotherapy +12

Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials

James C. Sullivan, Sandra De Meyer, Doug J. Bartels et al. · Clinical Infectious Diseases · 2013 · 165 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

1–5 of 32